“Wouldn't a better alternative, depending on ter
Post# of 148184
(Total Views: 477)
Posted On: 03/05/2021 3:31:19 PM
Re: 2MartiniGi #80903
“Wouldn't a better alternative, depending on terms, be to partner with someone like Samsung and get paid on each indication as EUAs and full approvals take place?”
Samsung is the manufacture of leronlimab. Much more than manufacturing is needed to move leronlimab forward as am approved drug in other indications.
Samsung is the manufacture of leronlimab. Much more than manufacturing is needed to move leronlimab forward as am approved drug in other indications.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼